OmicVision is an ambitious early-stage biotech start-up based in Copenhagen's renowned BioInnovation Institute (BII).
Our goal? To leverage the power of spatial proteomics and revolutionize precision medicine. Our forward-thinking platform allows us to delve into the complexities of protein expression at a single-cell level, unveiling unique insights into health and disease. Our commitment is to enable precision therapies powered by data, with a vision to drive significant enhancements in patient outcomes.
Curious? Begin with this seminal paper (1, 2) to trace our journey and see how we've evolved (3).
(1) https://www.nature.com/articles/d42473-023-00401-4
(2) https://www.nature.com/articles/s41587-022-01302-5
(3) https://www.nature.com/articles/s41592-023-02007-6
#DeepVisualProteomics #DVP
Company Details
- Employees
- 10
- Founded
- 2023
- Address
- Ole Maaløes Vej 3, Nørrebro,capital Region Of Denmark 2200,denmark
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.omicvision.com
- HQ
- Nørrebro, Capital Region of Denmark
Omicvision Biosciences Questions
Omicvision Biosciences's website is http://www.omicvision.com
Omicvision Biosciences's LinkedIn profile is https://dk.linkedin.com/company/omicvision-biosciences
Omicvision Biosciences has
10 employees.
View email and phone details for 10
employees at Omicvision Biosciences.
Omicvision Biosciences's industry is
Biotechnology Research
Omicvision Biosciences's top competitors are
Lundbeck,
Gubra,
Bavarian Nordic,
Minerva Imaging,
Novo Nordisk,
Amass,
Evosep Biosystems,
Bits In Bio,
Preomics,
Bioinnovation Institute.
Omicvision Biosciences's categories are Biotechnology Research
Omicvision Biosciences's founding year is 2023
